Integer Holdings Corp

Integer Holdings Corp(ITGR)の株式分析

$126.700

0.000 (0.00%)終値時点

Loading chart…
高値
126.830
始値
126.730
出来高加重平均価格
126.74
出来高
764.08K
時価総額
3.84B
安値
126.700
売買代金
96.84M
EV/EBITDA(TTM)
17.05

Integer Holdings Corporation is a medical device contract development and manufacturing company. The Company serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets. Its brands include Greatbatch Medical and Lake Region Medical. The Company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. Its interventional cardiology portfolio is focused primarily on the design, development and manufacture of catheter and wire-based technologies intended to diagnose and treat cardiac disease. Its electrophysiology products include devices used by electrophysiologists and interventional cardiologists for the treatment of cardiac arrythmias, such as atrial fibrillation.

AI分析 of Integer Holdings Corp (ITGR)

中立

Integer Holdings Corp is currently a hold. The stock is trading at $126.70, very close to the acquisition price of $127, which limits upside potential. The RSI is at 71.16, indicating it is overbought, and the forward P/E ratio is 22.42, suggesting it may be fairly valued at this price point. The primary risk is the recent downgrade by analysts, which reflects concerns about future performance post-acquisition.

アナリスト評価(5)

-31.93% 下落余地
中立
2 買い
3 中立
0 売り
現在: 126.70
安値
75.00
平均
86.25
高値
95.00

Benchmark

2026-08-13

目標株価

—

中立

Piper Sandler

2026-08-03

目標株価

$127

中立

KeyBanc

2026-08-03

目標株価

$127

Sector Weight

BofA

2026-08-03

目標株価

—

No Rating

Freedom Capital

2026-07-22

目標株価

$112

買い

バリュエーション指標

Integer Holdings Corp(ITGR)の現在の予想PERは22.42で、5年平均は18.69です。

予想PER

割高
5年平均 P/E
18.69
現在のP/E
22.42
割高
21.77
割安
15.61

予想EV/EBITDA

大幅な割高
5年平均 EV/EBITDA
12.85
現在のEV/EBITDA
17.05
割高
14.51
割安
11.18

予想PSR

適正
5年平均 P/S
1.90
現在のP/S
2.23
割高
2.24
割安
1.56

Alphio AI による ITGR の価格シナリオ

シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

強

強気

強気 · 25%ITGR

$140.04

シナリオ価格

基

基本

基本 · 50%ITGR

$133.90

シナリオ価格

弱

弱気

弱気 · 25%ITGR

$130.08

シナリオ価格

ITGR を保有するクジラ

N

Nomura Holdings, Inc.

+ を保有ITGR

+2.59%

3か月リターン

H

Heartland Advisors, Inc.

+ を保有ITGR

+1.11%

3か月リターン

イベントタイムライン

2026-09-30 (ET)

08:30:00

Integer Holdings Receives Early Termination of Antitrust Waiting Period

2026-08-04 (ET)

06:30:00

Freedom Capital Downgrades Integer to Hold, Price Target $127

2026-08-03 (ET)

17:00:00

U.S. Stocks Rise as Middle East Tensions Ease, Oil Prices Drop 5%

17:00:00

Oppenheimer Downgrades Integer to Perform

12:00:00

Amazon's Market Cap Surpasses $3 Trillion

ニュース

ITGR のよくある質問 — Alphio AI が回答

Integer Holdings Corporation is a medical device contract development and manufacturing company. The Company serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets. Its brands include Greatbatch Medical and Lake Region Medical. The Company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. Its interventional cardiology portfolio is focused primarily on the design, development and manufacture of catheter and wire-based technologies intended to diagnose and treat cardiac disease. Its electrophysiology products include devices used by electrophysiologists and interventional cardiologists for the treatment of cardiac arrythmias, such as atrial fibrillation. It operates in the Healthcare sector (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry).

Integer Holdings Corp is currently a hold. The stock is trading at $126.70, very close to the acquisition price of $127, which limits upside potential. The RSI is at 71.16, indicating it is overbought, and the forward P/E ratio is 22.42, suggesting it may be fairly valued at this price point. The primary risk is the recent downgrade by analysts, which reflects concerns about future performance post-acquisition.

5 analysts cover ITGR: 2 rate it Buy, 3 Hold and 0 Sell. The average price target is 86.25.

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める